Figure 1 (Figure1)
Losartan Potassium Tablets, 50 Mg Tablet
Product Images NDC 63629-9192
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium Tablets, 50 Mg (NDC 63629-9192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Figure2)
The text is a table showing the percentage of patients with fatal and non-fatal stroke who were treated with Atenolol and Losartan Potassium. The table also provides the adjusted risk reduction percentages and p-values for both treatments. The Study Month column indicates the duration of the study.*
Figure 3 (Figure3)
This is a graph (Figure 3) that shows the primary endpoint events in demographic subgroups for patients taking Losartan and Atenolol for stroke prevention. The graph is divided into different subgroups such as age, gender, race, diabetes, and history of CVD. The primary endpoint is a composite stroke that is fatal or non-fatal. The graph displays the number of events, the rate of events, and the hazard ratio for both Losartan and Atenolol. The symbols on the graph are proportional to sample size, and the hazard ratio is adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy. The text provides additional information on the subgroup breakdowns and results that favor Losartan or Atenolol.*
Figure 4.jpg (Figure4)
This text is presenting data related to a clinical trial comparing the risk reduction of Losartan Potassium with Placebo. The percentage of patients who experienced an event is shown as 80%, and the risk reduction rate is 16.1%. Unfortunately, there is no context or information provided about the type of event, the nature of the clinical trial, or the units of measurement.*
Label (Lbl636299192)
This is a pharmaceutical label for Losartan Potassium tablets with a strength of 50mg. The label provides dosage instructions and storage precautions, including protecting from light and keeping the container tightly closed. The National Drug Code (NDC) for the product is 63629-9192-01, and it is for prescription use only.*
Losartan Potassium, Usp (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
